Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Onyebujoh

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|June 20, 2018
Response to the Ebola virus disease outbreak in the Democratic Republic of the CongoJohn N Nkengasong, Philip Onyebujoh
Lancet (London, England)|March 21, 2006
Priorities in tuberculosis researchPhilip Onyebujoh, William Rodriguez, Peter Mwaba
Current Opinion in HIV and AIDS|January 7, 2017
Improving laboratory efficiencies to scale-up HIV viral load testingGeorge Alemnji, Philip Onyebujoh, John N Nkengasong
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2002
Reinfection with Mycobacterium tuberculosis in an urban tuberculosis hospitalManormoney Pillay, Philip Onyebujoh, A. Willem Sturm
Lancet (London, England)|March 19, 2018
Laboratory medicine in low-income and middle-income countries: progress and challengesJohn N Nkengasong, Katy Yao, Philip Onyebujoh
Current Opinion in Pulmonary Medicine|March 3, 2023
Advances in development of new tuberculosis vaccinesChristopher da Costa, Philip Onyebujoh, Georges Thiry, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 25, 2015
Impact of tuberculosis treatment and antiretroviral therapy on serial RD-1-specific quantitative T-cell readouts (QuantiFERON-TB Gold In-Tube), and relationship to treatment-related outcomes and bacterial burdenThuli Mthiyane, Roxana Rustomjee, Alex Pym, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2015
Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic ExtractionMaxwell T Chirehwa, Roxana Rustomjee, Thuli Mthiyane, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2017
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant TuberculosisMaxwell T Chirehwa, Helen McIlleron, Roxana Rustomjee, et al.
Clinics in Chest Medicine|November 21, 2009
Advances in immunotherapy for tuberculosis treatmentGavin J Churchyard, Gilla Kaplan, Dorothy Fallows, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|June 20, 2018
Response to the Ebola virus disease outbreak in the Democratic Republic of the CongoJohn N Nkengasong, Philip Onyebujoh
Lancet (London, England)|March 21, 2006
Priorities in tuberculosis researchPhilip Onyebujoh, William Rodriguez, Peter Mwaba
Current Opinion in HIV and AIDS|January 7, 2017
Improving laboratory efficiencies to scale-up HIV viral load testingGeorge Alemnji, Philip Onyebujoh, John N Nkengasong
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 28, 2002
Reinfection with Mycobacterium tuberculosis in an urban tuberculosis hospitalManormoney Pillay, Philip Onyebujoh, A. Willem Sturm
Lancet (London, England)|March 19, 2018
Laboratory medicine in low-income and middle-income countries: progress and challengesJohn N Nkengasong, Katy Yao, Philip Onyebujoh
Current Opinion in Pulmonary Medicine|March 3, 2023
Advances in development of new tuberculosis vaccinesChristopher da Costa, Philip Onyebujoh, Georges Thiry, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|May 25, 2015
Impact of tuberculosis treatment and antiretroviral therapy on serial RD-1-specific quantitative T-cell readouts (QuantiFERON-TB Gold In-Tube), and relationship to treatment-related outcomes and bacterial burdenThuli Mthiyane, Roxana Rustomjee, Alex Pym, et al.
Antimicrobial Agents and Chemotherapy|November 11, 2015
Model-Based Evaluation of Higher Doses of Rifampin Using a Semimechanistic Model Incorporating Autoinduction and Saturation of Hepatic ExtractionMaxwell T Chirehwa, Roxana Rustomjee, Thuli Mthiyane, et al.
Antimicrobial Agents and Chemotherapy|June 14, 2017
Pharmacokinetics of Pyrazinamide and Optimal Dosing Regimens for Drug-Sensitive and -Resistant TuberculosisMaxwell T Chirehwa, Helen McIlleron, Roxana Rustomjee, et al.
Clinics in Chest Medicine|November 21, 2009
Advances in immunotherapy for tuberculosis treatmentGavin J Churchyard, Gilla Kaplan, Dorothy Fallows, et al.
Pageof 2